AXIS MAX LIFE INSURANCE LIMITED A/C REVERSIONARY BONUS PARTICIPATING - EQUITY
Institution · data to Jun 2026
Disclosed value
₹1,131 Cr
Jun 2026 closes
At current prices
…
Current holdings
4
Tracked since
Mar 2025
Portfolio value over time
Sum of disclosed holdings across all combined entities, valued at each quarter's closing price.
Current holdings (Jun 2026)
| Company | Holding | QoQ | Value |
|---|---|---|---|
| Sagility Ltd | 2.83% | flat | ₹543 Cr |
| AAVAS Financiers Ltd | 3.15% | 0.27 | ₹376 Cr |
| Concord Biotech Ltd | 1.34% | 0.18 | ₹178 Cr |
| Capital Small Finance Bank Ltd | 2.62% | 0.28 | ₹35 Cr |
Portfolio Summary
Jun 2026As of Jun 2026, AXIS MAX LIFE INSURANCE LIMITED A/C REVERSIONARY BONUS PARTICIPATING - EQUITY — an institution tracked through public shareholding filings — disclosed 4 holdings in Indian listed companies worth ₹1,131 crore. The same holdings-at-filing-value basis put it at ₹2,332 crore in Mar 2026 (−51.5%). Solomo carries these filings back to Mar 2025.
Largest disclosed positions in Jun 2026: Sagility Ltd (SAGILITY — 2.83% of the company, ₹543 crore); AAVAS Financiers Ltd (AAVAS — 3.15% of the company, ₹376 crore); Concord Biotech Ltd (CONCORDBIO — 1.34% of the company, ₹178 crore); Capital Small Finance Bank Ltd (CAPITALSFB — 2.62% of the company, ₹35 crore).
Changes in the Jun 2026 filings: Stake raised in Capital Small Finance Bank Ltd (+0.28 pp), AAVAS Financiers Ltd (+0.27 pp). Stake reduced in Concord Biotech Ltd (−0.18 pp). No longer disclosed after the previous quarter: Max Healthcare Institute Ltd — which can mean a sale, a stake falling below the 1% disclosure line, or that name not filing this quarter.
| Quarter | Disclosed value | Change |
|---|---|---|
| Jun 2026 | ₹1,131 Cr | −51.5% |
| Mar 2026 | ₹2,332 Cr | +77.9% |
| Dec 2025 | ₹1,311 Cr | +0.1% |
| Sep 2025 | ₹1,309 Cr | +164% |
| Jun 2025 | ₹496 Cr | −70.4% |
| Mar 2025 | ₹1,672 Cr | - |